Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dom.13209 http://scihub22266oqcxt.onion/10.1111/dom.13209 C5947126!5947126!29316157     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 261.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Obes+Metab 2018 ; 20 (5): 1306-10 Nephropedia Template TP {{tp|p=29316157|t=2018. Dapagliflozin for prednisone?induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease |pdf=|usr=}}{{29316157}} gab.com Text Dapagliflozin for prednisone induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease JO: Diabetes Obes Metab http://www.kidney.de/pget.php?&tw=1&pmid=29316157 #FOAvip The aim of the present study was to compare the effectiveness and safety of add?on treatment with dapagliflozin to placebo in patients with prednisone?induced hyperglycaemia during treatment for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). We enrolled 46 patients hospitalized for an AECOPD in a multicentre double?blind randomized controlled study in which add?on treatment with dapagliflozin 10 mg was compared with placebo. Glycaemic control and incidence of hypoglycaemia were measured through a blinded subcutaneous continuous glucose monitoring device. Participants in the dapagliflozin group spent 54 ± 27.7% of the time in target range (3.9?10 mmol/L) and participants in the placebo group spent 53.6 ± 23.4% of the time in target range (P = .96). The mean glucose concentration was 10.1 mmol/L in the dapagliflozin group and 10.4 mmol/L in the placebo group (P = .66). One participant using dapagliflozin and 2 participants using placebo experienced symptomatic hypoglycaemia. Treatment with dapagliflozin was safe and there was no difference in risk of hypoglycaemia compared with placebo. Dapagliflozin did not result in better glycaemic control compared with placebo in participants with prednisone?induced hyperglycaemia during AECOPD. Twit Text FOAVip Dapagliflozin for prednisone induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease ????Diabetes Obes Metab http://www.kidney.de/pget.php?&tw=1&pmid=29316157 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29316157 #FOAvip English Wikipedia <ref>{{Cite pmid|29316157}}</ref> Dapagliflozin for prednisone?induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease #MMPMID29316157 Gerards MC; Venema GE; Patberg KW; Kross M; Potter van Loon BJ; Hageman IMG; Snijders D; Brandjes DP; Hoekstra JBL; Vriesendorp TM; Gerdes VEA Diabetes Obes Metab 2018[May]; 20 (5): 1306-10 PMID29316157show ga The aim of the present study was to compare the effectiveness and safety of add?on treatment with dapagliflozin to placebo in patients with prednisone?induced hyperglycaemia during treatment for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). We enrolled 46 patients hospitalized for an AECOPD in a multicentre double?blind randomized controlled study in which add?on treatment with dapagliflozin 10 mg was compared with placebo. Glycaemic control and incidence of hypoglycaemia were measured through a blinded subcutaneous continuous glucose monitoring device. Participants in the dapagliflozin group spent 54 ± 27.7% of the time in target range (3.9?10 mmol/L) and participants in the placebo group spent 53.6 ± 23.4% of the time in target range (P = .96). The mean glucose concentration was 10.1 mmol/L in the dapagliflozin group and 10.4 mmol/L in the placebo group (P = .66). One participant using dapagliflozin and 2 participants using placebo experienced symptomatic hypoglycaemia. Treatment with dapagliflozin was safe and there was no difference in risk of hypoglycaemia compared with placebo. Dapagliflozin did not result in better glycaemic control compared with placebo in participants with prednisone?induced hyperglycaemia during AECOPD. äDapagliflozin for prednisone?induced hyperglycaemia in acute exacerbat(epmc).pdf DeepDyve Pubget Overpricing